Colchicine in the treatment of the cutaneous manifestations of Behçet's disease.
Five patients with Behçet's disease were satisfactorily treated with colchicine. Oral aphthosis, erythema nodosum-like lesions and genital erosions improved greatly within a month as did laboratory findings. We believe colchicine to be the first choice in the management of the cutaneous and ocular lesions of Behçet's disease.
D000328:Adult; D001528:Behcet Syndrome / Q000188:drug therapy*; D003078:Colchicine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D003078:Colchicine